Discontinued — last reported Q3 '21
Business Segments · Net Restructuring Charges
Lab Corp Diagnostics — Net Restructuring Charges
Labcorp Holdings Lab Corp Diagnostics — Net Restructuring Charges decreased by 45.0% to $3.30M in Q3 2021 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityModerate
First reportedQ1 2015
Last reportedQ3 2021
How to read this metric
High charges indicate active cost-cutting or structural transformation, while low charges suggest a stable operating environment.
Detailed definition
This represents the net costs incurred to reorganize the Diagnostics segment's operations, including severance, facility...
Peer comparison
Standard metric for mature companies undergoing operational pivots; comparable to restructuring costs reported by other large laboratory or medical service providers.
Metric ID:
lh_segment_lab_corp_diagnostics_net_restructuring_chargesHistorical Data
2 periods
| Q2 '21 | Q3 '21 | |
|---|---|---|
| Value | $6.00M | $3.30M |
| QoQ Change | — | -45.0% |
Range$3.30M – $6.00M
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Labcorp Holdings's lab corp diagnostics — net restructuring charges?
- Labcorp Holdings (LH) reported lab corp diagnostics — net restructuring charges of $3.30M in Q3 2021.
- What does lab corp diagnostics — net restructuring charges mean?
- The net expense associated with reorganizing business operations to improve efficiency.